Sanofi hands back neurology gene therapy rights to VoyagerSanofi’s Genzyme unit has handed back rights to two neurology gene therapies to US biotech Voyager Therapeutics, as Share XSanofi hands back neurology gene therapy rights to Voyagerhttps://pharmaphorum.com/news/sanofi-hands-back-neurology-gene-therapy-rights-to-voyager/
